Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $128,639 - $184,790
-1,000 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $139 Million - $161 Million
-927,100 Reduced 99.89%
1,000 $164,000
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $15.6 Million - $19.9 Million
163,100 Added 21.32%
928,100 $102 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $28.2 Million - $49.1 Million
321,500 Added 72.49%
765,000 $76.3 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $23.7 Million - $31 Million
201,500 Added 83.26%
443,500 $66.2 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $5.7 Million - $6.52 Million
45,500 Added 23.16%
242,000 $31 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $12.1 Million - $13.9 Million
96,500 Added 96.5%
196,500 $28 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $12.2 Million - $14.3 Million
100,000 New
100,000 $14.3 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.92B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.